Dimethyl fumarate reduces the frequency and function of inflammatory immune cells in relapsing-remitting multiple sclerosis patients

被引：0
|
作者：
Diaz, G. Montes [1 ,2 ,3 ]
Fraussen, J. [1 ,2 ,3 ]
Van Wijmeersch, B. [1 ,2 ,3 ,4 ]
Hupperts, R. [5 ,6 ]
Somers, V. [1 ,2 ,3 ]
机构：
[1] Univ Limburg, Biomed Res Inst, Maastricht, Netherlands
[2] Univ Limburg, Transnat, Maastricht, Netherlands
[3] Hasselt Univ, Sch Life Sci, Diepenbeek, Belgium
[4] Rehabil & MS Ctr, Overpelt, Belgium
[5] Maastricht Univ, Sch Mental Hlth & Neurosci, Dept Neurosci, Maastricht, Netherlands
[6] Zuyderland Med Ctr, Acad MS Ctr Limburg, Sittard, Netherlands
来源：
MULTIPLE SCLEROSIS JOURNAL | 2017年 / 23卷
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P1169
引用
收藏
页码：616 / 617
页数：2
相关论文
共 50 条
  • [1] Actual adherence to dimethyl fumarate in patients with relapsing-remitting multiple sclerosis
    de Sa, Joao
    Ferreira, Joao
    Macedo, Ana M.
    REVISTA DE NEUROLOGIA, 2023, 76 : S1 - S6
  • [2] Dimethyl fumarate in the treatment of relapsing-remitting multiple sclerosis: an overview
    Bomprezzi, Roberto
    THERAPEUTIC ADVANCES IN NEUROLOGICAL DISORDERS, 2015, 8 (01) : 20 - 30
  • [3] Dimethyl Fumarate: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis
    Celeste B. Burness
    Emma D. Deeks
    CNS Drugs, 2014, 28 : 373 - 387
  • [4] Dimethyl Fumarate: A Review of Its Use in Patients with Relapsing-Remitting Multiple Sclerosis
    Burness, Celeste B.
    Deeks, Emma D.
    CNS DRUGS, 2014, 28 (04) : 373 - 387
  • [5] Dimethyl fumarate versus interferon for treatment of relapsing-remitting multiple Sclerosis
    Sattarnezhad, Neda
    Healy, Brian C.
    Baharnoori, Moogeh
    Diaz-Cruz, Camilo
    Stankiewicz, James
    Weiner, Howard L.
    Chitnis, Tanuja
    NEUROLOGY, 2017, 88
  • [6] Dimethyl fumarate: A guide to its use in relapsing-remitting multiple sclerosis
    Keating G.M.
    Burness C.B.
    Deeks E.D.
    Drugs & Therapy Perspectives, 2014, 30 (9) : 303 - 308
  • [7] Real world experience with dimethyl fumarate in relapsing-remitting multiple sclerosis
    Cox, S. R.
    Jordan, S.
    Sharma, D.
    O'Boyle, G.
    Tubridy, N.
    Hutchinson, M.
    Mcguigan, C.
    MULTIPLE SCLEROSIS JOURNAL, 2016, 22 : 614 - 615
  • [8] Comparative analysis of dimethyl fumarate and teriflunomide in relapsing-remitting multiple sclerosis
    Muller, Jannis
    Schadelin, Sabine
    Lorscheider, Johannes
    Benkert, Pascal
    Hanni, Peter
    Schmid, Jurg
    Kuhle, Jens
    Derfuss, Tobias
    Granziera, Cristina
    Yaldizli, Ozgur
    EUROPEAN JOURNAL OF NEUROLOGY, 2023, 30 (12) : 3809 - 3818
  • [9] EXTENDING THERAPEUTIC POSSIBILITIES IN RELAPSING-REMITTING MULTIPLE SCLEROSIS: DIMETHYL FUMARATE
    Matolcsi Judit
    Rozsa Csilla
    IDEGGYOGYASZATI SZEMLE-CLINICAL NEUROSCIENCE, 2015, 68 (1-2): : 7 - 14
  • [10] Comparative analysis of dimethyl fumarate and fingolimod in relapsing-remitting multiple sclerosis
    Lorscheider, Johannes
    Benkert, Pascal
    Lienert, Carmen
    Haenni, Peter
    Derfuss, Tobias
    Kuhle, Jens
    Kappos, Ludwig
    Yaldizli, Oezguer
    JOURNAL OF NEUROLOGY, 2021, 268 (03) : 941 - 949
12345